Fig. 5From: Emerging roles of Toll-like receptor 9 in cardiometabolic disordersRole of TLR9 in the development of cardiometabolic disorders. DNA fragments and/or nuclear proteins released from damaged cells/tissues activate immune cells such as macrophages and DCs through TLR9, leading to the development of inflammation in these tissues, which is central in the pathogenesis of cardiometabolic disordersBack to article page